Cargando...
Treatment with the phosphodiesterase type 4 inhibitor rolipram fails to inhibit blood brain barrier disruption in MS
Rolipram, a prototypic phosphodiesterase-4 inhibitor is highly effective in suppressing Th1 autoimmunity in multiple animal models, including experimental autoimmune encephalomyelitis (EAE). Additionally, Rolipram has been extensively studied as a potential neuroprotective agent. Based on its anti-i...
Gardado en:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2009
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3085182/ https://ncbi.nlm.nih.gov/pubmed/19776093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458509345903 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|